| Name | Title | Contact Details |
|---|
Founded in 2002, Concept Searching provides software products that deliver automatic semantic metadata generation, auto-classification, and powerful taxonomy management tools. Concept Searching, developer of the Smart Content Framework™, provides organizations with a method to mitigate risk, automate processes, manage information, protect privacy, and address compliance issues. This infrastructure framework utilizes a set of technologies that encompasses the entire portfolio of unstructured information assets, resulting in increased organizational performance and agility. Concept Searching is the only platform independent statistical metadata generation and classification software company in the world that uses concept extraction and compound term processing to significantly improve access to unstructured information. The Concept Searching Microsoft suite of technologies runs natively in all versions of SharePoint, Office 365, and OneDrive for Business. The technologies are being used to improve search outcomes, deploy an enterprise metadata repository, enable effective records management, identify and secure sensitive information, improve governance and compliance, social tagging, collaboration, text analytics, facilitate eDiscovery, and drive intelligent migration. Headquartered in the US with offices in the UK, South Africa and Canada, Concept Searching solves the problem of finding, organizing, and managing information capital far beyond search and retrieval.
Carousel Cloud is a hosted digital signage content management platform. It allows you to quickly create, publish and manage messages such as news feeds, calendars or emergency alerts.
Have some fun in Wisconsin Dells!
NuTEQ is a SaaS provider of mobile customer experience (“CX”) software. Our cloud-based, Intelligent Subscriber Management (“ISM”) platform aggregates consumer channel-of-choice interactions with the service provider in a “Mobile-First” world – WebChat...
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.